Pharmacy Times May 26, 2022

Dong Xu, PhD, MS, curators’ distinguished professor at the University of Missouri College of Engineering, discusses how the use of artificial intelligence may help develop new drug therapies targeting multiple disease states.

Pharmacy Times interviewed Dong Xu, PhD, MS, curators’ distinguished professor, Department of Electrical Engineering and Computer Science, University of Missouri College of Engineering, on research assessing the application of a form of artificial intelligence (AI) to help scientists develop new drug therapies for medical treatments targeting cancers and other diseases.

Alana Hippensteele: Hi, I’m Alana Hippensteele with Pharmacy Times. Joining me is Dong Xu, PhD, MS, a curators’ distinguished professor in the Department of Electrical Engineering and Computer Science at the University of Missouri College of Engineering, who...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Healthcare System, Interview / Q&A, Pharma / Biotech, Public Health / COVID, Technology, Trends
Brave launches a real-time privacy-focused AI answer engine
Watch out, Boston Dynamics! Mentee Robotics unveils 'AI-first' robot
The Use of Artificial Intelligence in Lung Cancer Management
Responsible AI Requires a Delicate Balancing Act
UniDoc Brings AI-Powered Health Cube to Alaska

Share This Article